Healthcare provider profile · identity verified

Paul Grayson Smith, D.O.

Family Practice · CLEVELAND, TN · NPI 1669543807

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Prednisone	Prednisone	733	416
Atorvastatin Calcium	Atorvastatin Calcium	663	214
Levothyroxine Sodium	Levothyroxine Sodium	585	175
Lisinopril	Lisinopril	527	160
Hydrochlorothiazide	Hydrochlorothiazide	409	130
Alendronate Sodium	Alendronate Sodium	399	140
Atenolol	Atenolol	327	103
Amlodipine Besylate	Amlodipine Besylate	316	105
Omeprazole	Omeprazole	311	105
Metformin Hcl	Metformin Hcl	306	100
Simvastatin	Simvastatin	296	91
Cephalexin	Cephalexin	275	204
Ciprofloxacin Hcl	Ciprofloxacin Hcl	271	202
Losartan Potassium	Losartan Potassium	248	76
Furosemide	Furosemide	201	82
Fluticasone Propionate	Fluticasone Propionate	192	78
Gabapentin	Gabapentin	186	67
Rosuvastatin Calcium	Rosuvastatin Calcium	167	60
Alprazolam	Alprazolam	166	27
Citalopram Hbr	Citalopram Hydrobromide	162	52
Pravastatin Sodium	Pravastatin Sodium	157	49
Glipizide Er	Glipizide	154	50
Meloxicam	Meloxicam	149	53
Pantoprazole Sodium	Pantoprazole Sodium	144	49
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	141	112
Famotidine	Famotidine	134	51
Finasteride	Finasteride	133	51
Zolpidem Tartrate	Zolpidem Tartrate	118	40
Metoprolol Tartrate	Metoprolol Tartrate	117	39
Ozempic	Semaglutide	117	25
Tamsulosin Hcl	Tamsulosin Hcl	115	45
Esomeprazole Magnesium	Esomeprazole Magnesium	112	36
Albuterol Sulfate Hfa	Albuterol Sulfate	111	49
Oxybutynin Chloride	Oxybutynin Chloride	109	36
Lorazepam	Lorazepam	106	16
Montelukast Sodium	Montelukast Sodium	103	30
Clopidogrel	Clopidogrel Bisulfate	102	36
Carvedilol	Carvedilol	97	34
Clonazepam	Clonazepam	94	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	94	52
Azithromycin	Azithromycin	93	86
Allopurinol	Allopurinol	84	23
Diclofenac Sodium	Diclofenac Sodium	83	38
Metoprolol Succinate	Metoprolol Succinate	78	28
Trazodone Hcl	Trazodone Hcl	74	30
Ezetimibe	Ezetimibe	72	22
Potassium Chloride	Potassium Chloride	72	27
Pregabalin	Pregabalin	72	29
Ropinirole Hcl	Ropinirole Hcl	69	21
Acyclovir	Acyclovir	63	49
Xarelto	Rivaroxaban	61	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	56	18
Eliquis	Apixaban	52	21
Paxlovid	Nirmatrelvir/Ritonavir	51	51
Fluoxetine Hcl	Fluoxetine Hcl	48	18
Sertraline Hcl	Sertraline Hcl	48	15
Diazepam	Diazepam	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	43	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	13
Metformin Hcl Er	Metformin Hcl	40	15
Glimepiride	Glimepiride	39	19
Jardiance	Empagliflozin	39	14
Gemfibrozil	Gemfibrozil	38	14
Synthroid	Levothyroxine Sodium	37	suppressed
Benazepril Hcl	Benazepril Hcl	36	13
Fenofibrate	Fenofibrate Nanocrystallized	34	12
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	34	11
Buspirone Hcl	Buspirone Hcl	32	11
Escitalopram Oxalate	Escitalopram Oxalate	31	12
Fluconazole	Fluconazole	31	20
Lovastatin	Lovastatin	30	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	18
Ibuprofen	Ibuprofen	26	12
Nystatin	Nystatin	26	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Metronidazole	Metronidazole	24	20
Celecoxib	Celecoxib	21	suppressed
Glipizide	Glipizide	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Ondansetron Odt	Ondansetron	21	17
Ramipril	Ramipril	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	17
Azelastine Hcl	Azelastine Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Metolazone	Metolazone	18	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	12
Bupropion Xl	Bupropion Hcl	16	suppressed
Carisoprodol	Carisoprodol	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	13
Mirtazapine	Mirtazapine	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Primidone	Primidone	16	suppressed
Myrbetriq	Mirabegron	15	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	13
Eszopiclone	Eszopiclone	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Linzess	Linaclotide	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error